IMAX Corp Files Q2 2024 10-Q Report

Ticker: IMAX · Form: 10-Q · Filed: 2024-07-25T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

IMAX Q2 2024 10-Q filed. Financials look steady, watch for growth in new markets.

AI Summary

IMAX Corp filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key financial figures and business segments are presented, reflecting the company's ongoing activities in the entertainment technology sector.

Why It Matters

This report provides investors and analysts with a detailed look into IMAX's financial health and strategic direction during the second quarter of 2024, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial disclosures with no immediate red flags.

Key Players & Entities

FAQ

What was IMAX Corp's revenue for the period ending June 30, 2024?

The filing does not explicitly state the total revenue figure in the provided snippet, but it is a key component of the full 10-Q report.

What is the company's fiscal year end?

IMAX Corp's fiscal year ends on December 31.

Where is IMAX Corp headquartered?

IMAX Corp's business and mailing address is 2525 SPEAKMAN DRIVE, MISSISSAUGA, A6, L5K 1B1.

What is the SEC file number for IMAX Corp?

The SEC file number for IMAX Corp is 001-35066.

What is the SIC code for IMAX Corp?

The Standard Industrial Classification (SIC) code for IMAX Corp is 3861, which corresponds to Photographic Equipment & Supplies.

Filing Stats: 4,624 words · 18 min read · ~15 pages · Grade level 18.2 · Accepted 2024-07-25 08:51:57

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements 3

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 41

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk 66

Controls and Procedures

Item 4. Controls and Procedures 68

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 69

Risk Factors

Item 1A. Risk Factors 69

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 70

Other Information

Item 5. Other Information 71

Exhibits

Item 6. Exhibits 72

Signatures

Signatures 73 2 Table of Contents IMAX CORPORATION

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Page The following unaudited Condensed Consolidated Financial Statements are filed as part of this Report: Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 4 Condensed Consolidated Statements of Operations for the three and six months ended June 30 , 2024 and 2023 5 Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30 , 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the six months ended June 30 , 2024 and 2023 7 Condensed Consolidated Statements of Shareholders' Equity for the three and six months ended June 30 , 2024 and 2023 8 Notes to Condensed Consolidated Financial Statements 9 3 Table of Contents IMAX CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands of U.S. Dollars, except share amounts) (Unaudited) June 30, December 31, 2024 2023 Assets Cash and cash equivalents $ 91,552 $ 76,200 Accounts receivable, net of allowance for credit losses 121,513 136,259 Financing receivables, net of allowance for credit losses 123,496 127,154 Variable consideration receivables, net of allowance for credit losses 69,927 64,338 Inventories 37,798 31,584 Prepaid expenses 11,786 12,345 Film assets, net of accumulated amortization 8,532 6,786 Property, plant and equipment, net of accumulated depreciation 237,781 243,299 Other assets 21,244 20,879 Deferred income tax assets, net of valuation allowance 16,099 7,988 Goodwill 52,815 52,815 Other intangible assets, net of accumulated amortization 34,856 35,022 Total assets $ 827,399 $ 814,669 Liabilities Accounts payable $ 20,055 $ 26,386 Accrued and other liabilities 106,336 111,013 Deferred revenue 62,655 67,105 Revolving credit facility borrowings, net of unamortized debt issuance costs 53,132 22,924 Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs 229,738 229,131 Deferred income tax liabilities 1

View on Read The Filing